Navigation Links
Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
Date:10/17/2007

BOULDER, Colo., Oct. 17 /PRNewswire-FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM) today announced the initiation of an international pivotal Phase 3 clinical trial evaluating amrubicin, the Company's third-generation synthetic anthracycline, in the treatment of second-line small cell lung cancer (SCLC). The randomized, controlled, multi-center study will compare amrubicin to topotecan, the only approved chemotherapy for second-line treatment of SCLC in the US and EU. Enrollment in the study of 480 patients is underway.

Approximately 30,000 patients in the US and 32,000 patients in the EU will be diagnosed with SCLC this year. "The treatment of small cell lung cancer is extremely challenging, given the limited therapeutic options available," said Mark A. Socinski, Associate Professor of Medicine, Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, and a principal investigator in the Phase 3 study. "Preliminary data suggest that amrubicin could represent a significant improvement in the treatment of small cell lung cancer, for which there have been no major medical advances in more than 20 years."

The study compares amrubicin and topotecan in second-line treatment of SCLC patients with sensitive or refractory disease. Sensitive disease is defined as response to first-line platinum-based therapy, with subsequent progression 90 days or more after completion of therapy. Refractory disease is defined as no objective response or progressive disease within 90 days of completion of therapy. Study participants are randomized in a 2:1 ratio to receive either IV amrubicin (40mg/m2 daily for 3 days) or topotecan (1.5 mg/m2 daily for 5 days), both starti
'/>"/>

SOURCE Pharmion Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
2. Pharmion to Present Clinical Data on Commercial and Pipeline Products at 2007 American Society of Clinical Oncology (ASCO) Meeting
3. Malvern initiates European user group meetings for chemical imaging
4. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
7. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
10. Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial Data
11. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... -- 3D Communications announced today that ... pharmaceutical companies communicate the value of their drugs ... newly expanded 3D Market Access and Reimbursement ... develop and deliver their "Value Story". It will also ... stakeholders earlier in the "innovation-to-market" timeline, and incorporate ...
(Date:5/6/2015)... SAN ANTONIO , May 6, 2015   GenSpera, ... "Injectable Cancer Compositions" has entered the national phase application process ... , Eurasia, Japan , China ... the United States . When awarded, the resulting patent ... property around its entire platform technology, including its lead drug ...
(Date:5/6/2015)... Advanced wound care - assess products, developments, ... future hold for the advanced wound care ... potential revenues to 2025, assessing data, trends, opportunities and ... provides 115 tables, charts, and graphs covering 12 distinct ... industry and the future market prospects. You will see ...
Breaking Medicine Technology:3D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 23D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 3GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 3Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 4Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 5Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 6
... Ohio, Sept. 13 AultCare has been using ... partnership with Cardiocom, released a white paper entitled, ... The paper describes the structure of the ... patient. Improved patient self-management has resulted in measurable ...
... 2010 Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ... and webcast on Friday, September 17, 2010, at 7:00 ... US Food and Drug Administration (FDA) Endocrinologic and Metabolic ... meet on September 16, 2010, to review the lorcaserin ...
Cached Medicine Technology:AultCare/Cardiocom® White Paper Shows Telehealth Services Reduce ER Visits and Inpatient Stays for Patients 2Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting 2Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting 3
(Date:5/7/2015)... 2015 When people think about protecting their ... their roofs than their basements. However, heavy rain falls also ... and basements. While flooding is an obvious problem in a ... unfinished areas dry to avoid a musty smell . ... Even small amounts of water can cause foundation damage, mold ...
(Date:5/7/2015)... Boston, MA (PRWEB) May 07, 2015 ... today the availability of its new free Alcohol ... is aimed at helping restaurant managers, professional bartenders, and ... earn their Alcohol Safety Certification. The material encompasses topics ... Upon completing the course, students can take the ServSafe ...
(Date:5/7/2015)... 07, 2015 “ Sky Hollywood Slots ” ... which takes a look at the latest and coolest applications ... the host of AppWatch and technology expert, conducted the app ... casino game that focuses on slots. , According to the ... traveled to Sin City in 2014. But what’s even more ...
(Date:5/7/2015)... Made with love at the Belvoir ... Vegan, no preservatives, no sweeteners or artificial colors and ... will delight every palate. , Belvoir Fruit Farms launched ... has grown successfully ever since. This range of refreshing ... opportunities as cocktail mixers. , Belvoir is available in ...
(Date:5/6/2015)... A poker run to raise funds for the 2015 National ... run will start at the United Veterans Club, 1914 W. Capital ... poker run, participants will visit checkpoints, drawing a card at each ... the end of the run. The run will start at the ... Tavern, Fairmont American Legion, Hastings DAV post, Kearney American Legion and ...
Breaking Medicine News(10 mins):Health News:Spring Storms Bring Musty Smell Inside 2Health News:Spring Storms Bring Musty Smell Inside 3Health News:Dynamic Path Adds Alcohol Safety Exam Prep Module to Test Preparation Offerings 2Health News:A Social Casino Game that Focuses on Slots Was Featured on NewsWatch Television 2Health News:Updated Contacts: Poker Run Fundraiser to Benefit National Veterans Golden Age Games 2
... This release is available in French . ... two can be spontaneously aggressive and that boys can be ... of boys will continue to be hyper-aggressive until the age ... sub-group of aggressive children has a different makeup than non-aggressive ...
... Inexpensive, well-established lab tests may hold the key ... which is the focus of World Kidney Day, March ... results in kidney failure, cardiovascular disease and anemia. ... percent over the past 10 years. But kidney disease ...
... others involved in tumor development , , TUESDAY, March 10 (HealthDay ... lower risk of developing pancreatic cancer, a finding that might ... , The study, by researchers at the Dana-Farber Cancer ... type and the disease, which is diagnosed in about 40,000 ...
... to Mount For Strawberry Nutrition BenefitsWATSONVILLE, Calif., March 10 ... of super foods that improve health and ... on time. A new study published in the scientific ... in strawberries help lower "bad" cholesterol.The study, conducted by ...
... technology programs implemented in New York state are active ... and could serve as models for new federal initiatives, ... Medical College. , "Programs such as these could transform ... says senior author Dr. Rainu Kaushal, chief of the ...
... Fee Offers Easy, Practical Strategies to Sleep Like a ... More...NEW YORK, March 10 Founder and CEO of ... announced her latest crusade -- educating people about the ... how to achieve high-quality sleep through her revolutionary wellness ...
Cached Medicine News:Health News:Perinatal environment influences aggression in children 2Health News:Upcoming World Kidney Day Underscores Role of Low-Cost Lab Tests in Combating High-Cost Kidney Disease 2Health News:Study Links Blood Type and Pancreatic Cancer 2Health News:Spoonfuls of Strawberries Help the Cholesterol Go Down 2Health News:Spoonfuls of Strawberries Help the Cholesterol Go Down 3Health News:New York State health IT strategy may be model for the nation 2Health News:New York State health IT strategy may be model for the nation 3Health News:Tired? Sleepless? ... New Sleep Program 'Good Night, Sleep Right(TM)' Launches in April 2009 2
Produce clean 0.75 mm round hole without tissue tags. Serrated squeeze action handle....
... CSV- lOOOHGT instrument provides standardized glare testing. It ... test faces for the evaluation of glare disability. ... precisely calibrated to simulate two on-coming halogen car ... The glare level can be adjusted to simulate ...
Designed to determine the precise length of limbal incisions and proper alignment of closing sutures. Curved marking blade with 2 mm lines spaced 1 mm apart-measures up to 10 mm. Round knurled handle...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Medicine Products: